Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H

被引:35
作者
Fan, Yongfeng [1 ]
Barash, Jason R. [2 ]
Lou, Jianlong [1 ]
Conrad, Fraser [1 ]
Marks, James D. [1 ]
Arnon, Stephen S. [2 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Anesthesia, Richmond, CA USA
[2] Calif Dept Publ Hlth, Ctr Infect Dis, Div Communicable Dis Control, Infant Botulism Treatment & Prevent Program, Richmond, CA USA
关键词
monoclonal antibodies; botulinum toxin; botulism; Clostridium botulinum; botulinum neurotoxin type H; bioterrorism; select agents; TOXIN TYPE-A; YEAST SURFACE DISPLAY; CLOSTRIDIUM-BOTULINUM; MOLECULAR EVOLUTION; BACILLUS BOTULINUS; SEROTYPE H; PROTEIN; ANTITOXIN; MANAGEMENT; AFFINITY;
D O I
10.1093/infdis/jiv770
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Only Clostridium botulinum strain IBCA10-7060 produces the recently described novel botulinum neurotoxin type H (BoNT/H). BoNT/H (N-terminal two-thirds most homologous to BoNT/F and C-terminal one-third most homologous to BoNT/A) requires antitoxin to toxin ratios = 1190: 1 for neutralization by existing antitoxins. Hence, more potent and safer antitoxins against BoNT/H are needed. Methods.aEuro integral We therefore evaluated our existing monoclonal antibodies (mAbs) to BoNT/A and BoNT/F for BoNT/H binding, created yeast-displayed mutants to select for higher-affinity-binding mAbs by using flow cytometry, and evaluated the mAbs' ability to neutralize BoNT/H in the standard mouse bioassay. Results.aEuro integral Anti-BoNT/A H-CC-binding mAbs RAZ1 and CR2 bound BoNT/H with high affinity. However, only 1 of 6 BoNT/F mAbs (4E17.2A) bound BoNT/H but with an affinity > 800-fold lower (equilibrium dissociation binding constant [K-D] = 7.56 x 10(-8) M) than its BoNT/F affinity (K-D = 9.1 x 10(-11) M), indicating that the N-terminal two-thirds of BoNT/H is immunologically unique. The affinity of 4E17.2A for BoNT/H was increased > 500-fold to K-D = 1.48 x 10(-10) M (mAb 4E17.2D). A combination of mAbs RAZ1, CR2, and 4E17.2D completely protected mice challenged with 280 mouse median lethal doses of BoNT/H at a mAb dose as low as 5 A mu g of total antibody. Conclusions.aEuro integral This 3-mAb combination potently neutralized BoNT/H and represents a potential human antitoxin that could be developed for the prevention and treatment of type H botulism.
引用
收藏
页码:1606 / 1614
页数:9
相关论文
共 41 条
[1]   Clinical Management of Potential Bioterrorism-Related Conditions [J].
Adalja, Amesh A. ;
Toner, Eric ;
Inglesby, Thomas V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (10) :954-962
[2]   Genetic and immunological comparison of anti-botulinum type A antibodies from immune and non-immune human phage libraries [J].
Amersdorfer, P ;
Wong, C ;
Smith, T ;
Chen, S ;
Deshpande, S ;
Sheridan, R ;
Marks, JD .
VACCINE, 2002, 20 (11-12) :1640-1648
[3]   Botulinum toxin as a biological weapon - Medical and public health management [J].
Arnon, SS ;
Schechter, R ;
Inglesby, TV ;
Henderson, DA ;
Bartlett, JG ;
Ascher, MS ;
Eitzen, E ;
Fine, AD ;
Hauer, J ;
Layton, M ;
Lillibridge, S ;
Osterholm, MT ;
O'Toole, T ;
Parker, G ;
Perl, TM ;
Russell, PK ;
Swerdlow, DL ;
Tonat, K .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (08) :1059-1070
[4]   A Novel Strain of Clostridium botulinum That Produces Type B and Type H Botulinum Toxins [J].
Barash, Jason R. ;
Arnon, Stephen S. .
JOURNAL OF INFECTIOUS DISEASES, 2014, 209 (02) :183-191
[5]   Automated kinetic exclusion assays to quantify protein binding interactions in homogeneous solution [J].
Blake, RC ;
Pavlov, AR ;
Blake, DA .
ANALYTICAL BIOCHEMISTRY, 1999, 272 (02) :123-134
[6]   THE N-TERMINAL HALF OF THE HEAVY-CHAIN OF BOTULINUM TYPE A NEUROTOXIN FORMS CHANNELS IN PLANAR PHOSPHOLIPID-BILAYERS [J].
BLAUSTEIN, RO ;
GERMANN, WJ ;
FINKELSTEIN, A ;
DASGUPTA, BR .
FEBS LETTERS, 1987, 226 (01) :115-120
[7]   Yeast surface display for directed evolution of protein expression, affinity, and stability [J].
Boder, ET ;
Wittrup, KD .
APPLICATIONS OF CHIMERIC GENES AND HYBRID PROTEINS, PT C: PROTEIN-PROTEIN INTERACTIONS AND GENOMICS, 2000, 328 :430-444
[8]   The occurrence of Bacillus botulinus in nature [J].
Burke, GS .
JOURNAL OF BACTERIOLOGY, 1919, 4 (05) :541-553
[9]   Notes on Bacillus botulinus [J].
Burke, GS .
JOURNAL OF BACTERIOLOGY, 1919, 4 (05) :555-571
[10]   Clinical Uses of Botulinum Neurotoxins: Current Indications, Limitations and Future Developments [J].
Chen, Sheng .
TOXINS, 2012, 4 (10) :913-939